AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BETAMETHASONE, CLOTRIMAZOLE & GENTAMICIN

10 registrations across 2 African markets— 9 active

Markets with BETAMETHASONE, CLOTRIMAZOLE & GENTAMICIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Jambact Cream
Cream
🇳🇬NigeriaJamin International Co. Nig. LtdactiveApr 2030
Smotbact Cream**
Cream
🇳🇬NigeriaVinco Pharmaceuticals Nigeria LimitedactiveJul 2029
Geederm Cream (strength format)
Cream
🇳🇬NigeriaSuitelife Pharmaceuticals LtdactiveDec 2028
Geoderm Cream (strength format)
Cream
🇳🇬NigeriaGreenlife Pharmaceutical LimitedactiveNov 2028
Gentaprox Cream
Cream
🇳🇬NigeriaHanbet Pharmaceuticals LimitedactiveMay 2028
Kescef Cream (strength format)
Cream
🇳🇬NigeriaKessington Global Synergy LtdactiveMar 2028
Digicloge Cream
Cream
🇳🇬NigeriaDigitall Healthcare LtdactiveDec 2026
Gentalene-C Cream
Cream
🇳🇬NigeriaRanbaxy Nigeria LimitedactiveMay 2026
Nuforce-G Cream
Cream
🇳🇬NigeriaPhillips Pharmaceuticals (Nigeria) LimitedactiveJan 2026
CLOTRISONE COMBINATION PRODUCT CREAM
CREAM
🇲🇼MalawiexpiredJun 2013

BETAMETHASONE, CLOTRIMAZOLE & GENTAMICIN in Africa — Regulatory Overview

BETAMETHASONE, CLOTRIMAZOLE & GENTAMICIN is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.